Albany Molecular Research Inc
AMRI
AMRI was delisted on the 31st of August, 2017.
142 hedge funds and large institutions have $394M invested in Albany Molecular Research Inc in 2016 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 38 reducing their positions, and 12 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
53% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 38
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
1% more funds holding
Funds holding: 141 → 142 (+1)
17% less capital invested
Capital invested by funds: $472M → $394M (-$78.7M)
98% less call options, than puts
Call options by funds: $1.47M | Put options by funds: $65.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIP
Permian Investment Partners
Dallas,
Texas
|
+$22.5M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$8.4M |
| 3 |
AAM
AMI Asset Management
Los Angeles,
California
|
+$4.57M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
+$4.07M |
| 5 |
RA
Royce & Associates
New York
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$30.7M |
| 2 |
ACM
American Capital Management
New York
|
-$19.9M |
| 3 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$6.23M |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$3.31M |
| 5 |
Renaissance Technologies
New York
|
-$2.99M |
AMRI Hedge Fund Activity: Q2 2016 in Review
142 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q2 2016, worth a combined $394M — down 17% from $472M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AMRI positions and 12 closed out — a net gain of 2 holders — while 58 added to existing stakes and 38 trimmed.
The largest buyer was Permian Investment Partners, adding an estimated $22.5M. The largest seller was Visium Asset Management, exiting entirely with an estimated $30.7M sold.
- 142 institutional investors held Albany Molecular Research Inc (AMRI) as of Q2 2016, up from 141 in Q1 2016.
- Funds reported $394M of Albany Molecular Research Inc stock for Q2 2016, down 17% quarter-over-quarter.
- 14 funds opened new Albany Molecular Research Inc positions in Q2 2016 and 12 closed out, a net change of +2 holders.
- The largest Albany Molecular Research Inc buyer in Q2 2016 was Permian Investment Partners, an estimated $22.5M added.
- The largest Albany Molecular Research Inc seller in Q2 2016 was Visium Asset Management, an estimated $30.7M sold.
Based on aggregated 13F filings for Q2 2016.